P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase

W Panenka, H Jijon, LM Herx… - Journal of …, 2001 - Soc Neuroscience
Leukocyte infiltration in the CNS after trauma or inflammation is triggered in part by upregulation
of the chemokine, monocyte chemoattractant protein-1 (MCP-1), in astrocytes. However …

Interleukin‐1 is a key regulator of matrix metalloproteinase‐9 expression in human neurons in culture and following mouse brain trauma in vivo

…, PH Larsen, SM Corley, LM Herx… - Journal of …, 2000 - Wiley Online Library
An acute trauma to the CNS rapidly results in the upregulation of inflammatory cytokines
that include interleukin‐1 (IL‐1). We report here that the levels of several matrix …

Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1β is required for the production of ciliary neurotrophic factor

LM Herx, S Rivest, VW Yong - The Journal of Immunology, 2000 - journals.aai.org
Injury to the CNS results in the production and accumulation of inflammatory cytokines within
this tissue. The origin and role of inflammation within the CNS remains controversial. In this …

Interleukin-1β is required for the early evolution of reactive astrogliosis following CNS lesion

LM Herx, VW Yong - Journal of Neuropathology & Experimental …, 2001 - academic.oup.com
The CNS response to injury is characterized by the rapid activation of astrocytes in a process
known as astrogliosis. The function of reactive astrocytes is controversial, in that both …

Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood–brain barrier

A Muruganandam, LM Herx, R Monette… - The FASEB …, 1997 - Wiley Online Library
The objective of this study was to generate an immortal cell line representative of specialized
human brain microvascular endothelia forming the blood–brain barrier (BBB) in vivo. …

Staffing a specialist palliative care service, a team-based approach: expert consensus white paper

JD Henderson, A Boyle, L Herx, A Alexiadis… - Journal of palliative …, 2019 - liebertpub.com
Palliative care is an evolving field with extensive studies demonstrating its benefits to
patients, families, and the health care system. Many health systems have developed or are …

Phase II trial of symptom screening with targeted early palliative care for patients with advanced cancer

…, AR Hansen, A Rydall, B Chow, L Herx… - Journal of the National …, 2021 - jnccn.org
Background: Routine early palliative care (EPC) improves quality of life (QoL) for patients
with advanced cancer, but it may not be necessary for all patients. We assessed the feasibility …

IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment

BM Lapointe, LM Herx, V Gill, LM Metz, P Kubes - Brain, 2004 - academic.oup.com
Several studies have reported beneficial effects of intravenous immunoglobulin (IVIg) in
diseases of the neuroaxis. However, IVIg effects on leucocyte recruitment, a hallmark feature of …

Deactivation of implantable cardioverter defibrillator in patients with terminal diagnoses

…, C Simpson, D Redfearn, H Abdollah, L Herx… - The American Journal of …, 2019 - Elsevier
Implantable cardioverter defibrillators (ICDs) prevent sudden cardiac death. However, in
patients with terminal illnesses, these devices may disrupt the dying process. This study was …

[HTML][HTML] Nonopioid drug combinations for cancer pain: a systematic review

…, A Caraceni, DE Moulin, C Zimmermann, L Herx… - Pain …, 2022 - journals.lww.com
Pain is highly prevalent in patients with cancer—nearly 40% report moderate-severe pain,
which is commonly treated with opioids. Increasing cancer survivorship, opioid epidemics in …